LLY Eli Lilly

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

$308.02  -3.45 (-1.11%)
As of 09/26/2022 14:26:23 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  950,174,817
Average volume:  2,737,490
Market cap:   $295,941,448,503
Current dividend yield:  1.21%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2516152
Valuation   (See tab for details)
PE ratio:   48.28
PB ratio:   30.05
PS ratio:   10.09
Return on equity:   65.69%
Net income %:   20.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy